787583-71-5

Basic information

• Product Name: [1,1'-Biphenyl]-4-carboxylic acid, 2'-[(1R)-1-[(2R)-3-[[2-(4-chloro-3-fluorophenyl)-1,1-diMethylethyl]aMino]-2-hydroxypropoxy]ethyl]-3-Methyl-
• Synonyms: [1,1'-Biphenyl]-4-carboxylic acid, 2'-[(1R)-1-[(2R)-3-[[2-(4-chloro-3-fluorophenyl)-1,1-diMethylethyl]aMino]-2-hydroxypropoxy]ethyl]-3-Methyl-;Encaleret;UNFHDRVFEQPUEL-DENIHFKCSA-N
• CAS NO: 787583-71-5
• Molecular Formula: C29H33ClFNO4
• Molecular Weight: 514.0280232
• Mol File: 787583-71-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: [1,1'-Biphenyl]-4-carboxylic acid, 2'-[(1R)-1-[(2R)-3-[[2-(4-chloro-3-fluorophenyl)-1,1-diMethylethyl]aMino]-2-hydroxypropoxy]ethyl]-3-Methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: [1,1'-Biphenyl]-4-carboxylic acid, 2'-[(1R)-1-[(2R)-3-[[2-(4-chloro-3-fluorophenyl)-1,1-diMethylethyl]aMino]-2-hydroxypropoxy]ethyl]-3-Methyl-(787583-71-5)
• EPA Substance Registry System: [1,1'-Biphenyl]-4-carboxylic acid, 2'-[(1R)-1-[(2R)-3-[[2-(4-chloro-3-fluorophenyl)-1,1-diMethylethyl]aMino]-2-hydroxypropoxy]ethyl]-3-Methyl-(787583-71-5)

Safety Data

• Hazardous Substances Data: 787583-71-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
[1,1'-Biphenyl]-4-carboxylic acid, 2'-[(1R)-1-[(2R)-3-[[2-(4-chloro-3-fluorophenyl)-1,1-dimethylethyl]amino]-2-hydroxypropoxy]ethyl]-3-methylis used as a potential pharmaceutical agent for its possible pharmacological activity due to the presence of a substituted amine group, which may contribute to its interaction with biological targets.
Used in Organic Synthesis:
In the field of organic synthesis, this compound serves as a building block or intermediate for the synthesis of more complex organic molecules, leveraging its biphenyl carboxylic acid group and unique amine substitution for the creation of novel chemical entities.
Used in Medicinal Chemistry:
[1,1'-Biphenyl]-4-carboxylic acid, 2'-[(1R)-1-[(2R)-3-[[2-(4-chloro-3-fluorophenyl)-1,1-dimethylethyl]amino]-2-hydroxypropoxy]ethyl]-3-methylis utilized in medicinal chemistry for the development of new drugs, given its structural complexity and the potential for it to be optimized for specific therapeutic targets.

Upstream product

• 5411-56-3 (1R)-1-(2-bromophenyl)ethan-1-ol 
• 787585-27-7 (2R)-2-{[(1R)-1-(2-bromo phenyl)ethoxy]methyl}oxirane 
• 787585-28-8 methyl 3-methyl-2'-{(1R)-1-[(2R)-oxiran-2-yl methoxy]ethyl}biphenyl-4-carboxylate 
• 525362-07-6 methyl 2-methyl-4-(4,4,5 ,5-tetramethyl-1,3 ,2-dioxaborolan-2-yl)benzoate 
• 1246560-95-1 tert-butyl 2'-((1R)-1-[(2R)-3-[1-(4-chloro-3-fluorophenyl)-2-methylpropan-2-ylamino]-2-hydroxypropoxy]ethyl)-3-methylbiphenyl-4-carboxylate 

Relevant articles and documents

Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormone

Short-acting oral calcilytics, calcium-sensing receptor (CaSR) antagonists, have been considered as alternatives for parathyroid hormone (PTH), an injectable bone anabolic drug used in the treatment of osteoporosis. Previously, we identified aminopropandi

PRODUCTION METHOD OF CARBOXYLIC ACID COMPOUND

The present invention provides the production method of carboxylic acid compound, as shown in Scheme I.

CaSR antagonist

A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof: wherein each symbol is as defined in the specification. A compound having a calcium-sensing receptor antagonistic action, a pharmaceutical composition comprising the compound, particularly a calcium receptor antagonist and a therapeutic drug for osteoporosis are provided.